The Future of the Adult Vaccine Market

The future of adult vaccines is set for exponential growth, the market expected to reach $28B by 2028

Established companies like GSK, Sanofi and Pfizer continue to forge ahead in the post-COVID-19 era, looking at new technologies and new engagement models. They face intense competition from emerging players such as  Moderna, BioNTech, Novavax, and CureVac, who are making waves with their innovative approaches

From cutting-edge mRNA vaccines to novel delivery methods, the vaccine landscape is rapidly changing, fueled by technological progress and an increasing emphasis on broader access to preventative healthcare

Is your organization ready to be at the forefront of this market transformation?

Sign up to download the full copy of the report.

Sign Up Here
Name*(Required)

The Future of the Adult
Vaccine Market

The future of adult vaccines is set for exponential growth, the market expected to reach $28B by 2028

Established companies like GSK, Sanofi and Pfizer continue to forge ahead in the post-COVID-19 era, looking at new technologies and new engagement models. They face intense competition from emerging players such as  Moderna, BioNTech, Novavax, and CureVac, who are making waves with their innovative approaches

From cutting-edge mRNA vaccines to novel delivery methods, the vaccine landscape is rapidly changing, fueled by technological progress and an increasing emphasis on broader access to preventative healthcare

Is your organization ready to be at the forefront of this market transformation?

Sign-up the get a copy of the full report.

 

The future of adult vaccines is set for exponential growth, the market expected to reach $28B by 2028

Established companies like GSK, Sanofi and Pfizer continue to forge ahead in the post-COVID-19 era, looking at new technologies and new engagement models. They face intense competition from emerging players such as  Moderna, BioNTech, Novavax, and CureVac, who are making waves with their innovative approaches

From cutting-edge mRNA vaccines to novel delivery methods, the vaccine landscape is rapidly changing, fueled by technological progress and an increasing emphasis on broader access to preventative healthcare

Is your organization ready to be at the forefront of this market transformation?

Sign up below to download the full copy of the report.

 

Sign Up Here
Name*(Required)
Sign Up Here
Name*(Required)